MENACTRA®
Suspension for Injection
registration number
44/30.1/1064
What MENACTRA® contains
Meningococcal (Serogroup A) Polysaccharide (Monovalent Conjugate) 4,0 mcg
Meningococcal (Serogroup C) Polysaccharide (Monovalent Conjugate) 4,0 mcg
Meningococcal (Serogroup Y) Polysaccharide (Monovalent Conjugate) 4,0 mcg
Meningococcal (Serogroup W-135) Polysaccharide (Monovalent Conjugate) 4,0 mcg
each of the four polysaccharides is conjugated to diphtheria toxoid : Diphtheria toxoid protein Approximately 48 mcg*
*Diphtheria Toxoid quantity is approximate and dependent on the conjugate polysaccharide to protein ratio.
There is no latex in any component of the single dose presentation.
other ingredients
Sodium Chloride
Dibasic Sodium Phosphate anhydrous
Water for injection.
Therapeutic classification
N/A.